| scholarly article | Q13442814 |
| P2093 | author name string | Li Chen | |
| Grant M Hatch | |||
| Wenguang Chang | |||
| P2860 | cites work | Efficacy of berberine in patients with type 2 diabetes mellitus | Q24645248 |
| Obesity and type 2 diabetes in children: epidemiology and treatment | Q26830006 | ||
| A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress | Q28264602 | ||
| Standards of medical care in diabetes--2014 | Q28304435 | ||
| Berberine Inhibits the Release of Glutamate in Nerve Terminals from Rat Cerebral Cortex | Q28533983 | ||
| Mitochondria and NMDA receptor-dependent toxicity of berberine sensitizes neurons to glutamate and rotenone injury | Q28542840 | ||
| Protective effect of berberine on antioxidant enzymes and positive transcription elongation factor b expression in diabetic rat liver | Q28564768 | ||
| Involvement of c-Jun N-terminal kinase in oxidative stress-mediated suppression of insulin gene expression | Q28568493 | ||
| Berberine attenuates lipopolysaccharide-induced extracelluar matrix accumulation and inflammation in rat mesangial cells: involvement of NF-κB signaling pathway | Q28573256 | ||
| Adipocyte differentiation from the inside out | Q29615690 | ||
| Berberine exerts anti-adipogenic activity through up-regulation of C/EBP inhibitors, CHOP and DEC2 | Q42806157 | ||
| Insulin sensitizing and insulinotropic action of berberine from Cortidis rhizoma | Q42811484 | ||
| Safety evaluation of main alkaloids from Rhizoma Coptidis | Q42828656 | ||
| Berberine stimulates glucose transport through a mechanism distinct from insulin. | Q42831138 | ||
| Berberine inhibits adipogenesis in high-fat diet-induced obesity mice | Q42832699 | ||
| Berberine ameliorates renal injury in diabetic C57BL/6 mice: Involvement of suppression of SphK-S1P signaling pathway | Q42963879 | ||
| Modulation of glucagon-like peptide-1 release by berberine: in vivo and in vitro studies | Q43234180 | ||
| Ameliorative effect of berberine on endothelial dysfunction in diabetic rats induced by high-fat diet and streptozotocin | Q43290690 | ||
| Berberine suppresses high glucose-induced TGF-β1 and fibronectin synthesis in mesangial cells through inhibition of sphingosine kinase 1/AP-1 pathway | Q44036628 | ||
| Berberine promotes glucagon-like peptide-1 (7-36) amide secretion in streptozotocin-induced diabetic rats | Q44118197 | ||
| Hippocampal synaptic plasticity restoration and anti-apoptotic effect underlie berberine improvement of learning and memory in streptozotocin-diabetic rats | Q44331287 | ||
| The antihyperglycaemic activity of berberine arises from a decrease of glucose absorption | Q44536650 | ||
| Effect of berberine administration on metabolic syndrome, insulin sensitivity, and insulin secretion | Q46092152 | ||
| Berberine ameliorates experimental diabetes-induced renal inflammation and fibronectin by inhibiting the activation of RhoA/ROCK signaling | Q46480430 | ||
| Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine | Q46656835 | ||
| Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action | Q46745033 | ||
| Berberine improves endothelial function by reducing endothelial microparticles-mediated oxidative stress in humans | Q47957732 | ||
| Long-term effects of nutraceuticals (berberine, red yeast rice, policosanol) in elderly hypercholesterolemic patients | Q50522082 | ||
| Berberine rescues D-galactose-induced synaptic/memory impairment by regulating the levels of Arc. | Q50702639 | ||
| Renoprotective effects of berberine and its possible molecular mechanisms in combination of high-fat diet and low-dose streptozotocin-induced diabetic rats | Q51348247 | ||
| Ameliorative effect of berberine on renal damage in rats with diabetes induced by high-fat diet and streptozotocin | Q51358502 | ||
| Berberine reducing insulin resistance by up-regulating IRS-2 mRNA expression in nonalcoholic fatty liver disease (NAFLD) rat liver | Q51369549 | ||
| Berberine ameliorates hyperglycemia in alloxan-induced diabetic C57BL/6 mice through activation of Akt signaling pathway | Q51371566 | ||
| Effect of berberine on expressions of uncoupling protein-2 mRNA and protein in hepatic tissue of non-alcoholic fatty liver disease in rats | Q53264353 | ||
| NADPH Oxidase 1 Plays a Key Role in Diabetes Mellitus–Accelerated Atherosclerosis | Q56991358 | ||
| Effects of berberine on diabetes induced by alloxan and a high-fat/high-cholesterol diet in rats | Q33246062 | ||
| Activation of AMP-Activated Protein Kinase Is Required for Berberine-Induced Reduction of Atherosclerosis in Mice: The Role of Uncoupling Protein 2 | Q34043189 | ||
| The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society | Q34292435 | ||
| Displacement of bilirubin from albumin by berberine | Q34366662 | ||
| Cardiovascular and metabolic effects of Berberine | Q34390654 | ||
| Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity | Q34603754 | ||
| Type 2 diabetes in children: clinical aspects and risk factors | Q34616312 | ||
| Youth-onset type 2 diabetes mellitus: lessons learned from the TODAY study | Q35057449 | ||
| ROS generation by nonphagocytic NADPH oxidase: potential relevance in diabetic nephropathy | Q35182347 | ||
| Berberine protects against high fat diet-induced dysfunction in muscle mitochondria by inducing SIRT1-dependent mitochondrial biogenesis | Q36006541 | ||
| Pilot study on the additive effects of berberine and oral type 2 diabetes agents for patients with suboptimal glycemic control | Q36175416 | ||
| The molecular basis for oxidative stress-induced insulin resistance | Q36184182 | ||
| Berberine Ameliorates Cold and Mechanical Allodynia in a Rat Model of Diabetic Neuropathy | Q36933488 | ||
| Clinical presentation and treatment of type 2 diabetes in children | Q36996546 | ||
| Effect of berberine on insulin resistance in women with polycystic ovary syndrome: study protocol for a randomized multicenter controlled trial | Q37042471 | ||
| Berberine behind the thriller of marked symptomatic bradycardia | Q37043236 | ||
| Sodium caprate augments the hypoglycemic effect of berberine via AMPK in inhibiting hepatic gluconeogenesis | Q37227111 | ||
| Preliminary study about the possible glycemic clinical advantage in using a fixed combination of Berberis aristata and Silybum marianum standardized extracts versus only Berberis aristata in patients with type 2 diabetes. | Q37337259 | ||
| The Crosstalk Between Nrf2 and AMPK Signal Pathways Is Important for the Anti-Inflammatory Effect of Berberine in LPS-Stimulated Macrophages and Endotoxin-Shocked Mice | Q37513209 | ||
| Neuropharmacological and pharmacokinetic properties of berberine: a review of recent research | Q37546190 | ||
| The role of uncoupling protein 2 (UCP2) on the development of type 2 diabetes mellitus and its chronic complications | Q37903726 | ||
| Berberine‐induced Haemolysis Revisited: Safety of Rhizoma coptidis and Cortex phellodendri in Chronic Haematological Diseases | Q37946266 | ||
| Metformin therapy and kidney disease: a review of guidelines and proposals for metformin withdrawal around the world | Q38130189 | ||
| Pharmacokinetic and toxicological considerations for the treatment of diabetes in patients with liver disease | Q38199526 | ||
| Amorphous solid dispersion of berberine with absorption enhancer demonstrates a remarkable hypoglycemic effect via improving its bioavailability | Q38418180 | ||
| Berberine improves insulin resistance in cardiomyocytes via activation of 5′-adenosine monophosphate-activated protein kinase | Q38421650 | ||
| Berberine Attenuates Ischemia-Reperfusion Injury Via Regulation of Adenosine-5′-monophosphate Kinase Activity in Both Non-ischemic and Ischemic Areas of the Rat Heart | Q38422854 | ||
| Global estimates of diabetes prevalence for 2013 and projections for 2035. | Q39231145 | ||
| Berberine activates Nrf2 nuclear translocation and protects against oxidative damage via a phosphatidylinositol 3-kinase/Akt-dependent mechanism in NSC34 motor neuron-like cells | Q39370584 | ||
| Berberine inhibits NADPH oxidase mediated superoxide anion production in macrophages | Q39714531 | ||
| Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression | Q39792130 | ||
| Berberine-induced LDLR up-regulation involves JNK pathway. | Q40085868 | ||
| Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK. | Q40218653 | ||
| Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states | Q40250572 | ||
| Characterization, pharmacokinetics, and hypoglycemic effect of berberine loaded solid lipid nanoparticles | Q42000200 | ||
| Berberine activates GLUT1-mediated glucose uptake in 3T3-L1 adipocytes | Q42521110 | ||
| Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARgamma pathway | Q42798170 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | type 2 diabetes | Q3025883 |
| P304 | page(s) | 479-486 | |
| P577 | publication date | 2014-12-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Biochemistry and Cell Biology | Q4914719 |
| P1476 | title | Berberine as a therapy for type 2 diabetes and its complications: From mechanism of action to clinical studies | |
| P478 | volume | 93 |
| Q89512877 | Autologous erythrocytes delivery of berberine hydrochloride with long-acting effect for hypolipidemia treatment |
| Q28550972 | Berberine Attenuates Development of the Hepatic Gluconeogenesis and Lipid Metabolism Disorder in Type 2 Diabetic Mice and in Palmitate-Incubated HepG2 Cells through Suppression of the HNF-4α miR122 Pathway |
| Q47753138 | Berberine Inhibits Oxygen Consumption Rate Independent of Alteration in Cardiolipin Levels in H9c2 Cells |
| Q49834498 | Berberine activates bitter taste responses of enteroendocrine STC-1 cells |
| Q36790209 | Berberine alleviates the cerebrovascular contractility in streptozotocin-induced diabetic rats through modulation of intracellular Ca²⁺ handling in smooth muscle cells |
| Q88092282 | Berberine enhances antidiabetic effects and attenuates untoward effects of canagliflozin in streptozotocin-induced diabetic mice |
| Q64084960 | Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics |
| Q92621370 | Berberine inhibits NLRP3 Inflammasome pathway in human triple-negative breast cancer MDA-MB-231 cell |
| Q38773397 | Berberine modulates cisplatin sensitivity of human gastric cancer cells by upregulation of miR-203. |
| Q90285326 | Berberine protects steatotic donor undergoing liver transplantation via inhibiting endoplasmic reticulum stress-mediated reticulophagy |
| Q47139281 | Berberis integerrima ameliorates insulin resistance in high- fructose-fed insulin-resistant rats |
| Q88419158 | Combating Neurodegenerative Diseases with the Plant Alkaloid Berberine: Molecular Mechanisms and Therapeutic Potential |
| Q55017149 | Composition and diversity of rhizosphere fungal community in Coptis chinensis Franch. continuous cropping fields. |
| Q46307017 | Could hop-derived bitter compounds improve glucose homeostasis by stimulating the secretion of GLP-1? |
| Q92826828 | Cytotoxic and Proapoptotic Activity of Sanguinarine, Berberine, and Extracts of Chelidonium majus L. and Berberis thunbergii DC. toward Hematopoietic Cancer Cell Lines |
| Q51019283 | Effects of type 2 diabetes mellitus on the pharmacokinetics of berberine in rats |
| Q60955679 | Enhancement of Berberine Hypoglycemic Activity by Oligomeric Proanthocyanidins |
| Q39374045 | Factors Influencing the Gut Microbiota, Inflammation, and Type 2 Diabetes. |
| Q28081001 | Immune Cell Regulatory Pathways Unexplored as Host-Directed Therapeutic Targets for Mycobacterium tuberculosis: An Opportunity to Apply Precision Medicine Innovations to Infectious Diseases |
| Q90632258 | Plant-Based Antidiabetic Nanoformulations: The Emerging Paradigm for Effective Therapy |
| Q64114596 | Preparation and Characterization of Erythrocyte Membrane-Camouflaged Berberine Hydrochloride-Loaded Gelatin Nanoparticles |
| Q42434705 | Renoprotective effects of berberine as adjuvant therapy for hypertensive patients with type 2 diabetes mellitus: Evaluation via biochemical markers and color Doppler ultrasonography |
| Q42492483 | The Compound of Mangiferin-Berberine Salt Has Potent Activities in Modulating Lipid and Glucose Metabolisms in HepG2 Cells |
| Q64354593 | The Pathogenesis of Diabetes Mellitus by Oxidative Stress and Inflammation: Its Inhibition by Berberine |
Search more.